Antibody molecules to PD-1 and uses thereof

US9683048B2 · kind B2 · utility

Assignees

• Novartis AG · CH
• DANA-FARBER CANCER INSTITUTE, INC. · US
• President and Fellows of Harvard College · US

Inventors

• Gordon J. Freeman · Brookline, US
• Arlene H. Sharpe · Brookline, US
• Walter A. Blattler · Brookline, US
• Jennifer Marie Mataraza · Cambridge, US
• Catherine Anne Sabatos-Peyton · Cambridge, US
• Hwai Wen Chang · San Marcos, US
• Gerhard Frey · San Diego, US

Key dates

• Filing date: Jan 23, 2015
• Grant date: Jun 20, 2017
• Expiry date: Jan 23, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

Antibody molecules that specifically bind to PD-1 are disclosed. The anti-PD-1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.